34. SAFETY OF USING SINGLE-NUCLEAR CELL CONTAINING STEM CELLS FROM THE AUTOLOGOUS BONE MARROW IN TREATING CHILDREN WITH CEREBRAL PALSY DUE TO ASPHYXIA IN VINMEC TIMES CITY HOSPITAL
Main Article Content
Abstract
Objective: Research using single -nuclear cell containing stem cells from autologous bone marrow in treating children with cerebral palsy due to brain hypoxia at birth was accepted at the Ministry of Science and Technology in September 2018. Initial results showed safety and evidence of effectiveness. The objective of this study is to confirm the safety of a single -nuclear cell containing stem cells from autologous bone marrow on a larger sample size in children with cerebral palsy due to asphyxia at birth.
Subjects and methods: This is a restrospective-perspective combined conducted in more than 50 cerebral palsy patients due to asphyxia that has been infused the single cell containing stem cells from the autologous bone marrow at Vinmec International Hospital. The Safety was assessed during the first and second transfusion and throughout the 12-month study period.
Results: There were no serious adverse events identified as associated with transfusion of single -nuclear cell containing stem cells from autologous bone marrow in treating children with cerebral palsy due to brain hypoxia.
Conclusion: Using single -nuclear cell masses containing stem cells from the autologous bone marrow in the treatment of children with cerebral palsy due to asphyxia is safe.
Article Details
Keywords
Stemcell, cerebral palsy.
References
report: the definition and classification of cerebral
palsy April 2006; Dev Med Child Neurol Suppl
2007, 109:8-14.
[2] Pavlichenko N, Sokolova I, Vijde S et al.,
Mesenchymal stem cells transplantation could be
beneficial for treatment of experimental ischemic
stroke in rats; Brain Res 2008, 1233:203-213.
[3] Nguyen LT, Nguyen AT, Vu CD et al., Outcomes
of autologous bone marrow mononuclear cells
for cerebral palsy: an open label uncontrolled
clinical trial; BMC Pediatr 2017, 17(1):104.
[4] Dianne R PR, GROSS MOTOR FUNCTION
MEASURE (GMFM) SCORE SHEET, 2013
[cited 2017; Available from: https://canchild.ca/
system/tenon/assets/attachments/000/000/218/
original/gmfm-88_and_66_scoresheet.pdf.
[5] Richard B MS, Modified Ashworth Scale
Instructions, [cited 2017; Available from:
http://www.rehabmeasures.org/PDF%20
Library/Modified%20Ashworth%20Scale%20
Instructions.pdf.
[6] Sharma A, Sane H, Gokulchandran N et al.,
A clinical study of autologous bone marrow
mononuclear cells for cerebral palsy patients: a
new frontier; Stem Cells Int 2015, 2015:905874.
[7] Eggenberger S, Boucard C, Schoeberlein A et al.,
Stem cell treatment and cerebral palsy: Systemic
review and meta-analysis; World J Stem Cells
2019, 11(10):891-903.
[8] Lv ZY, Li Y, Liu J, Progress in clinical trials
of stem cell therapy for cerebral palsy. Neural
Regen Res 2021, 16(7):1377-1382.